LXRP - Lexaria Bioscience Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
1.4800
+0.0300 (+2.07%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close1.4500
Open1.5000
Bid0.00 x 0
Ask0.00 x 0
Day's Range1.4600 - 1.5000
52 Week Range0.7500 - 2.4300
Volume316,604
Avg. Volume186,126
Market Cap114.893M
Beta (3Y Monthly)4.03
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Newsfile17 days ago

    CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp. Creating Subsidiaries, Carving Opportunity in Global Cannabis Industry

    New York, New York--(Newsfile Corp. - February 1, 2019) - CannabisNewsAudio announces the Audio Press Release (APR) titled "Outside Investment, New Technology Support Growing Cannabis Industry," featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP).To hear the CannabisNewsAudio version, visit: http://cnw.fm/uXf6S To read the full editorial, visit: http://cnw.fm/H3q7rTo make the most of this potential, Lexaria has created subsidiaries specializing in the use of DehydraTECH for cannabis. Lexaria CanPharm Corporation focuses on the cannabis market, providing ...

  • GlobeNewswire17 days ago

    CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp. Gaining Appeal in Cannabis Edibles with DehydraTECH

    NEW YORK, Feb. 01, 2019 -- via CannabisNewsWire – CannabisNewsAudio announces the Audio Press Release (APR) titled “Outside Investment, New Technology Support Growing Cannabis.

  • GlobeNewswire18 days ago

    CannabisNewsWire Announces Publication on Cannabis Industry Innovations and Advancements Drawing Investment from Big Corporations

    NEW YORK, Jan. 31, 2019 -- via CannabisNewsWire – CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an.

  • GlobeNewswire26 days ago

    NetworkNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp.’s Proprietary Technology Levels Field with Big Players in Bioscience

    NEW YORK, Jan. 23, 2019 -- via NetworkWire – NetworkNewsAudio announces the Audio Press Release (APR) titled “Definitive Agreement Marks Milestone for Alternative Nicotine.

  • GlobeNewswirelast month

    NetworkNewsWire Announces Publication on Innovators at the Door of Big Tobacco in Quest for Cigarette Alternatives

    NEW YORK, Jan. 17, 2019 -- via NetworkWire — NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial.

  • GlobeNewswirelast month

    Altria Group Invests Up to $12M in Lexaria Bioscience’s DehydraTECH™ Technology

    KELOWNA, British Columbia, Jan. 17, 2019 -- via NetworkWire -- Lexaria Nicotine LLC, a wholly owned subsidiary of Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX), has entered.

  • Newsfilelast month

    Altria Group Invests Up to $12M in Lexaria Bioscience's DehydraTECH(TM) Technology

    Kelowna, British Columbia--(Newsfile Corp. - January 17, 2019) - Lexaria Nicotine LLC, (OTCQX: LXRP) (CSE: LXX) a wholly owned subsidiary of Lexaria Bioscience Corp. has entered into a definitive agreement with Altria Group Inc. (NYSE: MO) to fund the research & development of Lexaria's patented DehydraTECH™ technology. Lexaria's DehydraTECH™ enhances the performance of beneficial compounds in ingestible products across four categories: taste & smell, speed of action, bio-absorption and bioavailability. The partnership will ...

  • ACCESSWIRElast month

    Lexaria Bioscience Announces Partnership with Altria to Fund Research and Development of DehydraTECH(TM) Technology for Oral Nicotine

    Lexaria Nicotine LLC and a subsidiary of Altria Group, Inc. have entered into a definitive investment agreement. The Altria investment will fund research on regulatory compliant, oral forms of nicotine ...

  • GlobeNewswirelast month

    Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018 -- CFN Media

    SEATTLE, Jan. 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Lexaria Biosciences Inc. (CSE:LXX) (CN) (CNSX:LXX) (LXRP). The company is a developer of drug delivery technologies for bioactive compounds, Lexaria is one of the oldest companies in the cannabis industry.

  • ACCESSWIRE2 months ago

    Lexaria Bioscience Expands Staff, Issues Options

    KELOWNA, BC / ACCESSWIRE / December 7, 2018 / Lexaria Bioscience Corp. (LXRP) (CNSX:LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces the following updates. In the New Year, Lexaria expects to begin hiring additional new laboratory personnel as its R&D operations intensify. As a result of the latest positions created, Lexaria is issuing 240,000 stock options with an exercise price of US$1.06, that will vest as to 80,000 per year until April 15, 2021.

  • Newsfile3 months ago

    CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp. Holds Enviable Position in Rise of Cannabis Edibles

    New York, New York--(Newsfile Corp. - November 30, 2018) -  CannabisNewsAudio announces the Audio Press Release (APR) titled "Booming Cannabis Consumables Space Continues to See Product Innovations," featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP).To hear the CannabisNewsAudio version, visit: http://cnw.fm/IxM3OTo read the full editorial, visit: http://cnw.fm/qzN9LLexaria's proprietary technology is patent protected for CBD and other nonpsychoactive cannabinoids and has patents pending for THC, other psychoactive cannabinoids, NSAIDs (non-steroidal anti-inflammatory drugs), nicotine and other ...

  • GlobeNewswire3 months ago

    CannabisNewsWire Announces Growing Cannabis Acceptance Setting Stage For Consumable Cannabis Boom

    NEW YORK, Nov. 29, 2018 -- via CannabisNewsWire -- CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company, today announces the publication of an.

  • ACCESSWIRE3 months ago

    Lexaria Bioscience Submits Application to Health Canada for Research License and Appoints Chief Legal Officer

    KELOWNA, BC / ACCESSWIRE / November 26, 2018 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces it has submitted a Health Canada research application, and appointed Dr. Ed Ergenzinger to its executive team. The Company has submitted its research application under Health Canada's Cannabis Tracking and Licensing System for the operation of a Kelowna-based R&D laboratory within Lexaria's new head office under construction, to work with cannabinoids. The laboratory will enhance Lexaria's ability to formulate for analytical purposes, various products that may contain cannabinoids or other controlled substances.

  • ACCESSWIRE3 months ago

    Lexaria Bioscience Launches ChrgD+

    KELOWNA, BC / ACCESSWIRE / November 13, 2018 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces the launch of ChrgD+, a water-soluble, ready-mix hemp supplement powder packet formulation designed to be added to any drink, in any location, creating many innovative-use applications. Consistent with other Lexaria formulations, ChrgD+ incorporates multi-spectrum hemp oil processed using the Company's patented DehydraTECHTM technology, allowing effective delivery of hemp oil into any existing beverage, hot or cold. "This new delivery format is truly unique in its performance," said Chris Bunka, CEO of Lexaria Bioscience.

  • ACCESSWIRE4 months ago

    Lexaria Bioscience Announces Increased Size and Closing of Private Placement

    KELOWNA, BC / ACCESSWIRE / October 31, 2018 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces that due to strong demand it has increased the size of its previously announced non-brokered private placement, closing on gross proceeds of US$1,515,440 (the "Offering"). Each Unit consists of one common share of the Company (a "Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant shall entitle the holder to acquire one common share of the Company at a price of US$2.25 per common share for a period of 24 months following the closing of the Offering.

  • Newsfile4 months ago

    CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp.'s Leadership Position in Booming Canadian Cannabis Market

    CannabisNewsAudio announces the Audio Press Release (APR) titled "Canada Leads International Cannabis Boom - and It's Not About Smoking," featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP).To hear the CannabisNewsAudio version, visit: http://cnw.fm/7n7B5To read the full editorial, visit: http://cnw.fm/6sImPAfter much political maneuvering, recreational cannabis is now legal in Canada in keeping with a promise made by Justin Trudeau when he was elected prime minister in 2015. The wait has been frustrating for some, but ...

  • ACCESSWIRE4 months ago

    Lexaria Bioscience Receives Two New Granted Patents

    KELOWNA, BC / ACCESSWIRE / October 18, 2018 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces it has been granted two new US patents. Lexaria now has six granted patents in the US and four granted patents in Australia. All ten of these patents are within Lexaria's first patent family, "Food and Beverage Compositions Infused With Lipophilic Active Agents and Methods of Use Thereof".

  • ACCESSWIRE4 months ago

    Lexaria Bioscience Creates and Brands Subsidiary Companies

    KELOWNA, BC / ACCESSWIRE / October 10, 2018 / Lexaria Bioscience Corp. (LXRP) (LXX.CN) (the ''Company'' or ''Lexaria''), a drug delivery platform innovator, is pleased to announce it has completed the creation of four wholly-owned subsidiary companies. This new corporate structure more suitably reflects the distinct customer bases and business applications for each subsidiary, thereby allowing the Company to focus its future research and consider financing structures and industry partnerships specifically optimized to each. The subsidiaries are each empowered with Lexaria's patented DehydraTECHTM technology.

  • Newsfile4 months ago

    CannabisNewsAudio Announces Audio Press Release (APR) on Lexaria Bioscience Corp.'s Technology Has Opportunity for Immediate Impact in Multi-Billion Legal Cannabis Sector

    New York, New York--(Newsfile Corp. - October 8, 2018) - CannabisNewsAudio announces the Audio Press Release (APR) titled Intangible Assets Power Growth, Acquisitions in the Pharmaceuticals Sector," featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP).To hear the CannabisNewsAudio version, visit: http://cnw.fm/99vVo To read the full editorial, visit: http://cnw.fm/z0TDtThe legal global cannabis market started to emerge only recently, thanks to a handful of countries allowing medical marijuana. The market has started to mature through ...